This is a working overview of actin binding, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-09. Anything still debated is marked as such rather than presented as settled.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
=== Blood sugar and insulin levels === Erythritol has no effect on blood sugar or blood insulin levels, and therefore may be used as a sugar substitute by people with type 2 diabetes. The glycemic index (GI) of erythritol is 0% of the GI for glucose and the insulin index (II) is 2% of the II for glucose.
===== Conservation burial ===== Conservation burial is a type of burial where burial fees fund the acquisition and management of new land to benefit native habitat, ecosystems and species. This usually involves a legal document such as a conservation easement. Such burials go beyond other forms of natural burial, which aim to prevent environmental damage caused by conventional burial techniques, by actually increasing benefits for the environment. The idea is for the burial process to be a net positive for the earth rather than just neutral. Scientists have argued that such burials could potentially generate enough funds to save every endangered species on the planet. The Green Burial Council certifies natural and conservation burial grounds in the U.S. and Canada.
== Screening == Fasting plasma glucose screening should begin at age 30–45 and be repeated at least every three years. Earlier and more frequent screening should be conducted in at-risk individuals. The risk factors for which are listed below:
== F == fat redistribution – FDA FDC – floaters – follicle – follicular dendritic cells (FDCs) – Food and Drug Administration (United States) functional antibody – fungus – fusin – fusion inhibitor – fusion mechanism – fusion peptide
==== Other applications ==== Other MALS applications include nanoparticle sizing, protein aggregation studies, protein-protein interactions, electrophoretic mobility or zeta potential. MALS techniques have been adopted for the study of pharmaceutical drug stability, crystal nucleation and crystallization kinetics and use in nanomedicine.
Sources: en.wikipedia.org
=== Pseudomonas syringae pv. tomato strain DC3000 and Arabidopsis thaliana === As mentioned above, the genome of P. syringae pv. tomato DC3000 has been sequenced, and approximately 40 Hop (Hrp Outer Protein) effectors - pathogenic proteins that attenuate the host cell - have been identified. These 40 effectors are not recognized by A. thaliana thus making P. syringae pv. tomato DC3000 virulent against it - that is, P. syringae pv. tomato DC3000 is able to infect A. thaliana - thus A. thaliana is susceptible to this pathogen. Many gene-for-gene relationships have been identified using the two model organisms, P. syringae pv. tomato strain DC3000 and Arabidopsis. The gene-for-gene relationship describes the recognition of pathogenic avirulence (avr) genes by host resistance genes (R-genes). P. syringae pv. tomato DC3000 is a useful tool for studying avr: R-gene interactions in A. thaliana because it can be transformed with avr genes from other bacterial pathogens, and furthermore, because none of the endogenous hops genes is recognized by A. thaliana, any observed avr recognition identified using this model can be attributed to recognition of the introduced avr by A. thaliana. The transformation of P. syringae pv. tomato DC3000 with effectors from other pathogens have led to the identification of many R-genes in Arabidopsis to further advance knowledge of plant pathogen interactions.
The same month, she partnered with Models of Diversity to appear in a billboard campaign alongside a group of other women, raising awareness about the lack of diversity within fashion weeks. Collins said of the campaign that she was "Getting a bit sick of the fashion industry still not letting plus-size women walk the runways" adding that she felt "plus-size fashion was at an all time low" and that she was "shocked by how bad the regular sites had become". In November 2024, Collins attended the Swansea Christmas Parade as part of a collaboration with McDonald's for their "Gift Drop" campaign. For the event, she dressed in a red ball gown and offered the public the chance to try items from the companies' Festive Menu ahead of its launch, serving from a food van. In December 2024, after collaborating with Baileys Irish Cream and appearing at one of their events earlier in the year, she hosted The Baileys Christmas Sip and Sing event where she performed alongside The Gold Collective choir. Of the event, Collins said: "Tis the season to Baileys, honey! Christmas is all about bringing people together for a bit of festive joy, a Christmas singalong, and of course, some Baileys". In June 2025, Collins collaborated with the motorised kitchen appliances company Ninja to promote their slushy machine Ninja SLUSHi. In a social media video promoting the product, Collins was appointed the "GCEO" and expresses her distaste in the employees slushy ideas at a board meeting, before introducing her own that are based on her, named the "Gemma Tom Collins" and "Brentwood Bellini" respectively.
Proteoglycans - Including chondroitin sulfate and heparan sulfate, which bind to collagen and may regulate collagen fibril diameters and play a role in mineralization Osteocalcin - A bone-specific protein involved in binding calcium during the mineralization process Osteonectin - May serve a bridging function between collagen and the mineral component Bone sialoprotein - Proteins rich in sialic acid that participate in matrix organization Growth factors - Including transforming growth factors, fibroblast growth factors, and insulin-like growth factors
Chondronectin is a high molecular weight collagen matrix protein (~180 kDa), or also known as a glycoprotein, and is most commonly found in human synovial fluid. It is mainly responsible for binding chondrocytes and collagen II substrates together in the extracellular matrix (ECM). Chondronectin is characterized as a trimeric protein, that is linked with disulfide bonds. It also has been noted to appear compact and globular in nature. Chondronectin is responsible for helping anchor chondrocytes, bearing mechanical forces and even maintaining homeostasis on a physiological level. Chondronectin works within tissue, where it joins other proteins to build a strong but flexible framework. This structure helps keep joints stable during movement and repeated pressure. Without adhesive matrix proteins like chondronectin, cartilage tissue would have a harder time handling everyday mechanical stress. Chondronectin acts as a strong binding protein inside the body's joints. It helps attach important cartilage cells directly to tough collagen fibers. These cells main responsibility is maintaining healthy cartilage tissue. This protein helps the surrounding tissue structure stay firm and stable while keeping the cartilage properly organized. Without this important connection, the framework of the joins could gradually lose stability. The protein has a three part molecular shape that helps keep it structurally stable. It remains strong while interacting with nearby matrix tissues and surrounding support components.
Sources: en.wikipedia.org
=== Proteoglycans === Glycosaminoglycans (GAGs) are carbohydrate polymers and mostly attached to extracellular matrix proteins to form proteoglycans (hyaluronic acid is a notable exception; see below). Proteoglycans have a net negative charge that attracts positively charged sodium ions (Na+), which attracts water molecules via osmosis, keeping the ECM and resident cells hydrated. Proteoglycans may also help to trap and store growth factors within the ECM. Described below are the different types of proteoglycan found within the extracellular matrix.
In broad terms, spent nuclear fuel has three main components. The first consists of fission products, the leftover fragments of fuel atoms after they have been split to release energy. Fission products come in dozens of elements and hundreds of isotopes, all of them lighter than uranium. The second main component of spent fuel is transuranics (atoms heavier than uranium), which are generated from uranium or heavier atoms in the fuel when they absorb neutrons but do not undergo fission. The actinide series on the periodic table runs from actinium to lawrencium and includes uranium as well as transuranic elements. The third and largest component is the remaining uranium which is around 98.25% uranium-238, 1.1% uranium-235, and 0.65% uranium-236. The U-236 comes from the non-fission capture reaction where U-235 absorbs a neutron but releases only a high energy gamma ray instead of undergoing fission. The physical behavior of the fission products is markedly different from that of the actinides. In particular, fission products do not undergo fission and therefore cannot be used as nuclear fuel. Indeed, because fission products are often neutron poisons (absorbing neutrons that could be used to sustain a chain reaction), fission products are viewed as nuclear 'ashes' left over from consuming fissile materials. Furthermore, only seven long-lived fission product isotopes have half-lives longer than a hundred years, which makes their geological storage or disposal less problematic than for transuranic materials.
Smith in his review largely agreed with Waschman's point about that Peukert's focus on developments entirely within Germany was limited one. However, Smith argued that Peukert's "subtle understanding of consent, accommodation and non-conformity" by ordinary people in Nazi Germany still made him relevant today as Peukert helped show how the absence of "public protest and genuine outrage at the treatment of others" made genocide possible. In 2017, the British historian Jane Caplan approvingly quoted Peukert's remarks about how best to confront fascism as still relevant today, citing his statement from Inside Nazi Germany: "The values we should assert [in response to fascism] are easily stated but hard to practise: reverence for life, pleasure in diversity and contrariety, respect for what is alien, tolerance for what is unpalatable, scepticism about the feasibility and desirability of chiliastic schemes for a global new order, openness towards others and a willingness to learn even from those who call into question one's own principles of social virtue."
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.